Repligen Corporation (RGEN) Social Stream
Repligen Corp (RGEN) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering Repligen Corp.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
RGEN's average price target has moved up $142.3 over the prior 21 months.
Over the past 49 weeks, RGEN's average upside potential has been 19.81%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
RGEN Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 28 days, RGEN's average broker recommendation rating improved by 0.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In the context of all US stocks, Repligen Corp's average analyst price target is greater than 564.4% of them.
- Repligen Corp's upside potential (average analyst target price relative to current price) is higher than 491.24% of stocks in the large market cap category.
- RGEN has a greater number of analysts covering the stock than 476.34% of Pharmaceutical Products stocks.
- Repligen Corp's variance in analysts' estimates is lower than -264.28% of stocks in the large market cap category.
Make investment decisions regarding RGEN using the data that counts. Try POWR Ratings for free.